mRNA in cancer immunotherapy: beyond a source of antigen

被引：0

作者：

Lien Van Hoecke

Rein Verbeke

Heleen Dewitte

Ine Lentacker

Karim Vermaelen

Karine Breckpot

Sandra Van Lint

机构：

[1] VIB-UGent Center for Inflammation Research,Department of Biomedical Molecular Biology

[2] Ghent University,Ghent Research Group on Nanomedicines, Lab for General Biochemistry and Physical Pharmacy, Department of Pharmaceutical Sciences

[3] Ghent University,Cancer Research Institute Ghent (CRIG)

[4] Ghent University,Tumor Immunology Laboratory, Department of Respiratory Medicine and Immuno

[5] Ghent University Hospital,Oncology Network Ghent

[6] Vrije Universiteit Brussel,Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences

来源：

Molecular Cancer | / 20卷

关键词：

Cancer; mRNA; Nanoparticle; Antibody; Dendritic cell; T cell; Cytokine; Tumor microenvironment;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

mRNA therapeutics have become the focus of molecular medicine research. Various mRNA applications have reached major milestones at high speed in the immuno-oncology field. This can be attributed to the knowledge that mRNA is one of nature’s core building blocks carrying important information and can be considered as a powerful vector for delivery of therapeutic proteins to the patient.

引用

共 50 条

[1] mRNA in cancer immunotherapy: beyond a source of antigen
Van Hoecke, Lien
Verbeke, Rein
Dewitte, Heleen
Lentacker, Ine
Vermaelen, Karim
Breckpot, Karine
Van Lint, Sandra
MOLECULAR CANCER, 2021, 20 (01)
[2] mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond
Senti, Mariona Estape
del Valle, Lucia Garcia
Schiffelers, Raymond M.
ADVANCED DRUG DELIVERY REVIEWS, 2024, 206
[3] mRNA vaccines for cancer immunotherapy
Vishweshwaraiah, Yashavantha L.
Dokholyan, Nikolay V.
FRONTIERS IN IMMUNOLOGY, 2022, 13
[4] mRNA delivery in cancer immunotherapy
Zhong, Yichen
Du, Shi
Dong, Yizhou
ACTA PHARMACEUTICA SINICA B, 2023, 13 (04) : 1348 - 1357
[5] mRNA vaccine for cancer immunotherapy
Miao, Lei
Zhang, Yu
Huang, Leaf
MOLECULAR CANCER, 2021, 20 (01)
[6] mRNA therapeutics in cancer immunotherapy
Beck, Jan D.
Reidenbach, Daniel
Salomon, Nadja
Sahin, Ugur
Tureci, Ozlem
Vormehr, Mathias
Kranz, Lena M.
MOLECULAR CANCER, 2021, 20 (01)
[7] mRNA delivery in cancer immunotherapy
Yichen Zhong
Shi Du
Yizhou Dong
Acta Pharmaceutica Sinica B, 2023, (04) : 1348 - 1357
[8] mRNA vaccine for cancer immunotherapy
Lei Miao
Yu Zhang
Leaf Huang
Molecular Cancer, 20
[9] mRNA therapeutics in cancer immunotherapy
Jan D. Beck
Daniel Reidenbach
Nadja Salomon
Ugur Sahin
Özlem Türeci
Mathias Vormehr
Lena M. Kranz
Molecular Cancer, 20
[10] Sperm Protein 17: Clinical Relevance of a Cancer/Testis Antigen, from Contraception to Cancer Immunotherapy, and Beyond
Chiriva-Internati, Maurizio
INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2011, 30 (2-3) : 138 - 149

← 1 2 3 4 5 →